CN102895574B - Medicament for treating acute gastritis - Google Patents

Medicament for treating acute gastritis Download PDF

Info

Publication number
CN102895574B
CN102895574B CN201210439891.1A CN201210439891A CN102895574B CN 102895574 B CN102895574 B CN 102895574B CN 201210439891 A CN201210439891 A CN 201210439891A CN 102895574 B CN102895574 B CN 102895574B
Authority
CN
China
Prior art keywords
parts
medicament
rhizoma
fructus
acute gastritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210439891.1A
Other languages
Chinese (zh)
Other versions
CN102895574A (en
Inventor
毛利进
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210439891.1A priority Critical patent/CN102895574B/en
Publication of CN102895574A publication Critical patent/CN102895574A/en
Application granted granted Critical
Publication of CN102895574B publication Critical patent/CN102895574B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a medicament for treating acute gastritis. The medicament is prepared from the following Chinese herbal medicines in part by weight: 5 to 16 parts of pinellia tuber, 5 to 16 parts of calyx kaki, 5 to 10 parts of clove, 15 to 25 parts of fructus crataegi, 5 to 16 parts of officinal magnolia flower, 5 to 16 parts of bitter orange, 5 to 16 parts of chicken gizzard membrane, 10 to 19 parts of dandelion, 3 to 6 parts of coptis root, 5 to 16 parts of liquoric root, 10 to 19 parts of glabrous greenbrier rhizome, 15 to 25 parts of dried red date and 5 to 16 parts of large-head atractylodes rhizome. The medicament is reasonable in formula and exact in curative effect, and can be used for effectively treating acute gastritis.

Description

A kind of medicament for the treatment of acute gastritis
Technical field
The present invention relates to tcm field, specifically, relate to a kind of medicament for the treatment of acute gastritis.
Background technology
Acute gastritis can belong to the categories such as Chinese medicine gastric abscess, dampness, vomiting according to primary disease clinical symptoms.This cause of disease improper diet, the sense wind and cold of holding concurrently, diet disorder of the spleen and stomach caused by internal damage, spleen loses transporting, cold-damp invading in the interior, damage yang-energy, checks mechanism of qi, causes hypoactivity of spleen-YANG, failure of the spleen to transport and transform, abnormal ascending-descending of QI.Wet in upper nose heave, headache; Wet in feel sick nausea, anorexia, the vexed abdominal distention of gastral cavity; Wet at next dysuria, diarrhea with loose stool; , myalgia tired at skin, body acid body wet; Pale tongue, the thick serious symptom greasy, that soft pulse cunning is cold-damp disturbing the spleen, retention of dampness in middle-JIAO of moist and slippery fur show.
The demand of the current treatment for acute gastritis increases day by day.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of acute gastritis.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of acute gastritis, it is to be made by weight by following bulk drugs: Rhizoma Pinelliae 5-16 part, Calyx Kaki 5-16 part, Flos Caryophylli 5-10 part, Fructus Crataegi 15-25 part, Flos Magnoliae Officinalis 5-16 part, Fructus Aurantii 5-16 part, Endothelium Corneum Gigeriae Galli 5-16 part, Herba Taraxaci 10-19 part, Rhizoma Coptidis 3-6 part, Radix Glycyrrhizae 5-16 part, Rhizoma Smilacis Glabrae 10-19 part, the dry 15-25 part of Fructus Jujubae and Rhizoma Atractylodis Macrocephalae 5-16 part.
Preferably, the medicament for the treatment of acute gastritis of the present invention is to be made by weight by following bulk drugs: 10 parts of 10 parts of the Rhizoma Pinelliaes, 10 parts of Calyx Kaki, 8 parts of Flos Caryophyllis, 20 parts of Fructus Crataegis, 10 parts of Flos Magnoliae Officinalises, 10 parts of Fructus Aurantiis, 10 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Herba Taraxacis, 5 parts of Rhizoma Coptidis, 10 parts, Radix Glycyrrhizae, 15 parts of Rhizoma Smilacis Glabraes, Fructus Jujubae dry 20 parts and the Rhizoma Atractylodis Macrocephalaes.
Pharmaceutical composition of the present invention can be made various dosage forms with pharmaceutically acceptable carrier, such as tablet, capsule, soft capsule, pill, powder, drop pill or decoction etc.Can adopt preparation technique means well known in the art to complete the preparation of pharmaceutical composition of the present invention.
Described pharmaceutically acceptable carrier is well known, is the usual excipients for the preparation of above-mentioned preparation or adjuvant.Conventional excipient or adjuvant comprises (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant etc., for example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate etc.
The reasonable recipe of medicament of the present invention, curative effect is clear and definite, can be used for effectively treating acute gastritis.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get 100 grams of 100 grams of the Rhizoma Pinelliaes, 100 grams of Calyx Kaki, 80 grams of Flos Caryophyllis, 200 grams of Fructus Crataegis, 100 grams of Flos Magnoliae Officinalises, 100 grams of Fructus Aurantiis, 100 grams of Endothelium Corneum Gigeriae Galli, 150 grams of Herba Taraxacis, 50 grams of Rhizoma Coptidis, 100 grams, Radix Glycyrrhizae, 150 grams of Rhizoma Smilacis Glabraes, Fructus Jujubae dry 200 grams and the Rhizoma Atractylodis Macrocephalaes, pulverize, cross 200 mesh sieves, then evenly pack in 100 bags, obtain powder of the present invention.
The effect of experimental example powder treatment of the present invention acute gastritis
Diagnostic criteria with reference to < < new Chinese medicine guideline of clinical investigations > > (Ministry of Health of the People's Republic of China. the 2nd volume of .[S of new Chinese medicine guideline of clinical investigations] 1995.110-112.) and in the diagnostic criteria of acute gastritis: 1. have feed chemistry, physical stimulation thing and containing microorganism, bacteriotoxic food history, often morbidity in 24 hours; 2. there is epigastric discomfort, pain, feel sick, the symptom such as vomiting, serious case can have heating, dehydration, acidosis, shock even, erosive gastritis often has upper gastrointestinal hemorrhage; 3. there are all tenderness of abdominal part or umbilicus; 4. visible gastric mucosa hyperemia, edema, secretions increase under gastroscope, or the phenomenon such as hemorrhage erosion.
Exclusion standard 1. the age at under-18s or over-65s, gestation or women breast-feeding their children; 2. severe trauma, operation, infection and with the patient of shock; 3. be associated with the serious primary disease such as cardiovascular, cerebrovascular, Liver and kidney and hemopoietic system and psychotic; 4. do not meet inclusive criteria, not medication in accordance with regulations, cannot judge curative effect, or data is not congruent affects the treatment or safety judgement person.
Choose patient's 40 examples that meet above-mentioned standard, age reckling 25 years old, the maximum 52 years old; Each 20 examples of men and women wherein.
Therapeutic Method:
Use the powder of preparation in embodiment 1, take every day 3 times, each serving with 3 bags.It within 7 days, is 1 course for the treatment of.
Curative effect determinate standard:
With reference to < < new Chinese medicine guideline of clinical investigations > > (Guan Siyou, Guan Yanfang. Chinese well-known doctor expert innovates grand ceremony [M]. Beijing: the traditional Chinese medical science Ancient Books Publishing House, 1998.109.) formulates.Recovery from illness: clinical symptoms, sign disappear; Effective: cardinal symptom, sign take a turn for the better more than 2 grades; Effective: cardinal symptom, sign take a turn for the better more than 1 grade; Invalid: not reach effective standard or increase the weight of.
Therapeutic outcome:
After treatment, whole 40 routine patients' epigastric discomfort, pain, feel sick, the symptom such as vomiting, and heating, dehydration, the acidosis of serious case, even suffer a shock, erosive gastritis often has the transference cure of all tenderness of upper gastrointestinal hemorrhage, abdominal part or umbilicus, and visible gastric mucosa hyperemia, edema, secretions increase under gastroscope, or the phenomenon disappearance such as hemorrhage erosion.As can be seen here, all patients all meets the standard of recovery from illness.

Claims (2)

1. a medicament for the treatment of acute gastritis, it is characterized in that, it is to be made by weight by following bulk drugs: Rhizoma Pinelliae 5-16 part, Calyx Kaki 5-16 part, Flos Caryophylli 5-10 part, Fructus Crataegi 15-25 part, Flos Magnoliae Officinalis 5-16 part, Fructus Aurantii 5-16 part, Endothelium Corneum Gigeriae Galli 5-16 part, Herba Taraxaci 10-19 part, Rhizoma Coptidis 3-6 part, Radix Glycyrrhizae 5-16 part, Rhizoma Smilacis Glabrae 10-19 part, the dry 15-25 part of Fructus Jujubae and Rhizoma Atractylodis Macrocephalae 5-16 part.
2. the medicament for the treatment of acute gastritis according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 10 parts of 10 parts of the Rhizoma Pinelliaes, 10 parts of Calyx Kaki, 8 parts of Flos Caryophyllis, 20 parts of Fructus Crataegis, 10 parts of Flos Magnoliae Officinalises, 10 parts of Fructus Aurantiis, 10 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Herba Taraxacis, 5 parts of Rhizoma Coptidis, 10 parts, Radix Glycyrrhizae, 15 parts of Rhizoma Smilacis Glabraes, Fructus Jujubae dry 20 parts and the Rhizoma Atractylodis Macrocephalaes.
CN201210439891.1A 2012-11-07 2012-11-07 Medicament for treating acute gastritis Expired - Fee Related CN102895574B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210439891.1A CN102895574B (en) 2012-11-07 2012-11-07 Medicament for treating acute gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210439891.1A CN102895574B (en) 2012-11-07 2012-11-07 Medicament for treating acute gastritis

Publications (2)

Publication Number Publication Date
CN102895574A CN102895574A (en) 2013-01-30
CN102895574B true CN102895574B (en) 2014-02-19

Family

ID=47568259

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210439891.1A Expired - Fee Related CN102895574B (en) 2012-11-07 2012-11-07 Medicament for treating acute gastritis

Country Status (1)

Country Link
CN (1) CN102895574B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194613A (en) * 2015-10-12 2015-12-30 阿迪拉·阿布来提 Traditional Chinese medicine composition for treating acute gastritis and preparation method of traditional Chinese medicine composition
CN105233233A (en) * 2015-11-19 2016-01-13 李�杰 Traditional Chinese medicine compound treating chronic gastric ulcers and preparation method thereof
CN106109945A (en) * 2016-08-18 2016-11-16 王平安 A kind of colitis preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739783A (en) * 2005-09-16 2006-03-01 王俊 Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer
CN102145096A (en) * 2011-03-16 2011-08-10 毕可波 Decoction for treating helicobacter pylori-associated gastritis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739783A (en) * 2005-09-16 2006-03-01 王俊 Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer
CN102145096A (en) * 2011-03-16 2011-08-10 毕可波 Decoction for treating helicobacter pylori-associated gastritis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
徐景藩教授辨治胃病经验;陈静等;《吉林中医药》;20060131;第26卷(第1期);第5-6页 *
杨士元.胃脘痛的中医药辨证论治研究进展.《中国当代医药》.2012,第19卷(第15期),第17-18页.
胃脘痛的中医药辨证论治研究进展;杨士元;《中国当代医药》;20120531;第19卷(第15期);第17-18页 *
陈静等.徐景藩教授辨治胃病经验.《吉林中医药》.2006,第26卷(第1期),第5-6页.

Also Published As

Publication number Publication date
CN102895574A (en) 2013-01-30

Similar Documents

Publication Publication Date Title
CN101130030B (en) Medicine composition for treating nephropathy and uses of the same
CN101874874B (en) Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof
CN102872261B (en) The application of Physalis pubescens L. in the medicine of preparation treatment acute cholecystitis
CN105456897A (en) Traditional Chinese medicine composition containing argy wormwood leaf for treating spleen deficiency gasterasthenia type chronic gastritis
CN102895574B (en) Medicament for treating acute gastritis
CN102988744A (en) Medicine composition used for treating chronic gastritis, and preparation method thereof
CN103893329A (en) Pharmaceutical composition for treating irritable bowel syndrome
CN105832991A (en) Traditional Chinese medicine composition for treating gastritis
CN103041145B (en) Traditional Chinese medicine composition for treating exogenous fever
CN104771697A (en) Pharacetuical composition for treating cholecystitis
CN104548029A (en) Pharmaceutical composition for treating epigastric pain
CN104189368A (en) Traditional Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof
CN105267818B (en) A kind of Chinese medicine composition and preparation method thereof for treating epigastric pain
CN103463452B (en) A kind of medicine for the treatment of chronic atrophic gastritis
CN103041233A (en) Pharmaceutical composition for treating infantile diarrhea and preparation method thereof
CN103919895B (en) The Chinese medicinal liquor of a kind of the intestines and stomach coordinating, treatment constipation
CN101745093B (en) Medicine for quickly treating infantile chronic diarrhea
CN101502597B (en) Medicament for treating stomachache and preparation method thereof
CN104352675A (en) Traditional Chinese medicine oral decoction for treating paediatrical odontoprisis
CN104906472A (en) Traditional Chinese medicine composition for preventing and treating cough-variant asthma
CN103690802A (en) Aloe bowel-relaxing traditional Chinese medicine capsule
CN103536756A (en) Stomach nourishing Chinese medicine composition and preparation method thereof
CN103127359B (en) TCM (traditional Chinese medicine) bone-strengthening capsule for treating senile osteoporosis
CN102631619A (en) Traditional Chinese medicines for treating chronic superficial gastritis
CN102133358B (en) Oral administration Chinese medicinal capsules for treating tumors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140219

Termination date: 20171107

CF01 Termination of patent right due to non-payment of annual fee